Vitamin B6, or pyridoxine, is a water-soluble vitamin. It is the coenzyme of many enzymes including transaminases, deaminases and decarboxylases that produce neurotransmitters such as serotonin, dopamine, amphetamines and GABA. It is essential for the metabolism of amino acids and proteins (cofactor for about 60 enzymes). To become active it is converted to pyridoxal phosphate and eliminated in the urine as pyridoxic acid.
Vitamin B6 is found in cereals and yeasts, fruits and vegetables, meats and offal.
Although overt deficiency is rare, marginal deficiency appears to be common. One study found that 100% of the 174 university students tested showed some degree of vitamin B6 deficiency. Another study of 11,658 adults found that 71% of men and 90% of women did not meet the recommended daily intake for B6. Clinical signs and symptoms are not specific because this vitamin is required for the proper functioning of more than 60 enzymes; nevertheless, in cases of deficiency mainly dermatological, circulatory and neurological changes are observed.
Vitamin B6 contributes to normal energy metabolism, to the normal functioning of the nervous system, to the normal synthesis of cysteine and to the normal metabolism of homocysteine, to the reduction of fatigue, to the normal metabolism of glycogen and proteins, to normal mental function, to the formation of red blood cells, to the normal functioning of the immune system and to the regulation of hormonal activity.
Other name(s)
Pyridoxine, pyridoxamine, pyridoxal
Scientific name(s)
Pyridoxal-5'-Phosphate, Pyridoxine
Family or group:
Vitamins
Indications
Méthodologie de notation
EFSA approval.
Several randomized, double-blind controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohort or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or contradictory.
No clinical studies to date capable of demonstrating the indication.
Vitamin B6 deficiency is rare, leading to seborrhea (excessive secretion of sebum by the sebaceous glands), glossitis, a pellagroid erythema, polyneuropathy and even depression with manic episodes. It may be due to iatrogenic causes (treatment with isoniazid or D-penicillamine) or occur following pregnancy.
In cases of vitamin B6 deficiency in adults, the dose used is 2.5 to 25 mg per day for three weeks, then continue a maintenance dose of 1.5 to 2.5 mg per day.
Sideroblastic anemias are anemias related to iron utilization, characterized by inadequate use of iron by the bone marrow for heme synthesis despite adequate or increased iron stores. Sideroblastic anemias may be acquired or congenital.
Acquired sideroblastic anemias can be due, among other causes, to a vitamin B6 deficiency.
The most common congenital sideroblastic anemia is an X-linked form caused by heterozygous germline mutations in the ALAS2 gene (a gene involved in heme biosynthesis). Vitamin B6 (pyridoxine) is an essential cofactor for the enzyme produced by ALAS2, so patients may respond to pyridoxine supplementation.
Initially, vitamin B6 (pyridoxine) is used at a dose of 200 - 600 mg per day, then the dose is decreased to 30 to 50 mg per day if the response is adequate.